Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06661850 · ClinicalTrials.gov registry record
Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes
A clinical trial of Discogenic Low Back Pain, sponsored by Aclarion.
- Recruiting
- Registry status
- 300
- Enrollment target
- 7
- Study locations
NCT06661850 is a study of Discogenic Low Back Pain that is actively recruiting participants, run by Aclarion. The registered enrollment target is 300 participants. The trial reports 7 study locations across 5 states.
The verdict
NCT06661850, a study of Discogenic Low Back Pain, is actively recruiting participants, sponsored by Aclarion.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is looking into how safe and useful NOCISCAN is. NOCISCAN is a software as a Service (SaaS) tool that uses Magnetic Resonance (MR) spectroscopy. Nociscan (instead of 'It') leverages MRS to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. The randomized controlled trial will compare the blinded and unblinded cohorts and their corresponding surgical outcomes with the Nocigram reports, generated prior to treatment, for each patient."
Conditions Studied
Interventions
- PROCEDURE Fusion or TDR determined by investigator.
Study Locations (7)
California
- Scripps Health - La Jolla
- USC Keck Medical Center - Los Angeles
Illinois
- Northwestern University - Chicago
- Advocate Aurora Research Institute - Park Ridge
Florida
- University of Miami - Miami
Maryland
- Johns Hopkins Medicine - Baltimore
Texas
- Texas Back Institute - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06661850
The ClinicalTrials.gov registry entry for NCT06661850 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aclarion, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Discogenic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Fusion or TDR determined by investigator. is the first listed.
NCT06661850 reports 7 study locations spanning 5 distinct geographic areas - top geographies include California, Illinois, Florida.
Frequently Asked Questions
What is clinical trial NCT06661850 about?
NCT06661850 is a clinical study titled "Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes". This study is looking into how safe and useful NOCISCAN is. NOCISCAN is a software as a Service (SaaS) tool that uses Magnetic Resonance (MR) spectroscopy. Nociscan (instead of 'It') leverages MRS to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. ...
What is the current status of trial NCT06661850?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-06-11. Estimated completion is 2027-12-31.
What conditions does trial NCT06661850 study?
This clinical trial studies the following conditions: Discogenic Low Back Pain.
What interventions are being tested in trial NCT06661850?
The interventions under investigation include: Fusion or TDR determined by investigator. (PROCEDURE).
Who is sponsoring clinical trial NCT06661850?
This trial is sponsored by Aclarion, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06661850 being conducted?
This trial has 7 study locations across California, Florida, Illinois, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Discogenic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.